ACA Cardiovascular Named MedAxiom Corporate Partner

Offers new, equity-free consulting and management options for cardiologists developing ASCs or converting OBLs.

Published Tuesday, April 3, 2018 5:00 pm

 

MedAxiom is pleased to announce its corporate partnership with ACA Cardiovascular, an ambulatory surgery organization with more than 30 years of success. ACA Cardiovascular works with entrepreneurial cardiovascular specialists to maximize their reimbursement and generate new revenue.

 “As our members begin to explore new options for their outpatient strategies, converting their OBLs into ASCs or starting ASCs de novo is a solid approach,” said Joe Sasson, PhD, Executive Vice President, MedAxiom Ventures. “ACA offers proven expertise in this area and the very attractive option of not requiring equity in the development and management of the surgery center.”

ACA Cardiovascular’s hybrid OBL/ASC model optimizes CMS reimbursement per procedure through a combined center that is both an outpatient-based lab and ambulatory surgery center. This hybrid model allows physicians to bill through the ASC or OBL accordingly, optimizing CMS reimbursement per procedure. Expanding an OBL into this hybrid ASC also generates new revenue by adding CV specialties designated for an ASC.

As ACA continues our focus on the rapidly expanding cardiovascular outpatient market, we’re excited about our partnership with MedAxiom,” said Marc Toth, CMAA, ACA Cardiovascular CEO. “The opportunity to collaborate with the MedAxiom community allows us to stay on the leading edge of essential change in the healthcare transformation we’re experiencing.”

ACA’s comprehensive services include: analysis and financial forecast; pre-development planning; de novo development; converting OBLs and VACs; managed care contracting; ongoing management; physician partnership; and group purchasing. They are an efficient, experienced and economical one-source partner for forward-thinking cardiologists who are anticipating a continued shift to outpatient procedures and a loosening of cardiac procedure restrictions from CMS in 2021.

“What our clients value most is that we allow doctors to practice medicine, and administrators to run the practice,” continued Marc Toth. “We keep ASCs compliant, efficient, profitable and on top of the latest reimbursement changes, policies, and local and federal regulations.”

Meet Marc Toth at CV Transforum Spring’18, April 12-14, in Ponte Vedra Beach, FL. Marc will be part of a pre-conference presentation on April 12 on Developing an Ambulatory Strategy and the opening General Session panel discussion on the CV Healthcare Landscape Right Now. Also, ACA Cardiovascular will be an exhibitor at CV Transforum Spring’18.

Learn more about ACA Cardiovascular at http://www.acacardiovascular.com.